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Peptides are part of the host defense system against bacteria
and fungi in species right across the evolutionary scale.
However, endogenous antibacterial peptides are often com-
posed of 25 residues or more and, therefore, are not ideal
for therapeutic use. Hence it is of considerable interest to
design and engineer short peptides having antimicrobial
activity. Peptides composed of 18 amino acids, derived
from the N-terminal region of the 33-residue toxiri
pardaxin (PX), GFFALIPKDSSPLFKTLLSAVGSALSS-
SGEQE, were synthesized and examined for biological
activities. Peptide corresponding to the 1-18 stretch of PX
exhibited antimicrobial activity only against Escherichia
coli and not against Gram-positive microorganisms. The
peptide also did not possess hemolytic activity. Replacement
of P7 by A resulted in a peptide possessing both antibac-
terial and hemolytic activity. Substitution of both K residues
by Q in the 'A' analog resulted in a peptide having
only hemolytic activity. Conformational analysis of these
peptides and investigation of their model membrane perme-
abilizing activities indicated that selective activity can be
explained by their biophysical properties. Hence, by a
rational design approach based on biophysical principles,
it should be possible to generate short peptides having
specific biological activity.
Keywords: antimicrobial activity/hemolysis/pardaxin/synthetic
peptides
Introduction
There has been considerable interest in recent years in various
aspects of the structure and biological activities of endogenous
antibacterial and hemolytic peptides which form part of the
host defense mechanism of species right across the evolutionary
scale (Boman and Hultmark, 1987; Bevins and Zasloff, 1990;
Boman, 1991; Lehrer et al, 1991; Hultmark, 1993). Detailed
investigations have revealed how these endogenous peptides
exert their activity and also structural requirements necessary
for activity (Christensen et al, 1988; Duclohier et al, 1989;
Kagan et al, 1990; Hill et al, 1991; Sansom, 1991). Based
on this knowledge, there have been attempts to synthesize
'designer peptides' with improved biological activity (DeGrado
and Lear, 1985; Lee et al, 1986; Boman et al, 1989; Blondelle
and Houghten, 1992). An important aspect in the design of
such model peptides has been to explore whether short peptides
(~15—18 residues) have biological activity (Houghten et al,
1991; Andreu et al, 1992; Blondelle et al, 1994) as the
endogenous peptides are often >25 residues in length (Boman
and Hultmark, 1987; Bevins and Zasloff, 1990; Boman, 1991;
Lehrer et al, 1991; Hultmark, 1993).
Our approach to generating designer peptides has involved
the analysis of the sequences of endogenous antibacterial or
hemolytic peptides in order to delineate regions that may
contribute to activity, synthesize peptides corresponding to
these regions as well as their variants and examine their
biological activity (Saberwal and Nagaraj, 1989, 1993; Sitaram
and Nagaraj, 1990; Sitaram et al, 1992, 1993, 1995; Dhople
and Nagaraj, 1995; Thennarasu and Nagaraj, 1995). Based on
the activities observed, they were further 'engineered' in order
to generate analogs with improved and/or specific activity and
also delineate the features required for optimal activity (Dhople
and Nagaraj, 1995; Sitaram et al, 1995). By this approach we
have obtained 13-residue peptides corresponding to the most
hydrophobic region of a 47-residue antibacterial protein,
seminalplasmin, having antibacterial activity (Sitaram and
Nagaraj, 1990; Sitaram et al, 1992, 1993, 1995). Likewise,
we have also obtained 16-residue peptides related to the
a-helical region of the hemolytic toxin 8-hemolysin having
hemolytic and/or antibacterial activity (Dhople and Nagaraj,
1995). In this study, we chose the 33-residue toxin pardaxin
as the target molecule. Pardaxin is secreted by the sole fish of
the genus Pardachirus (Lazarovici et al, 1986). The toxin is
presumed to play a role in the defense mechanism of the fish
against predators. Lipid bilayers doped with pardaxin at
concentrations below 10"7 M show single-channel conductance
behavior (Morah et al, 1984). At concentrations of -lO"4 M,
pardaxin causes cytolysis (Lazarovici et al, 1986). The peptide
also exhibits several other pharmacological effects, including
exocytosis of bovine adrenal medullary chromatin granules
(Lazarovici and Lelkes, 1993) and release of acetylcholine
from electric organ synaptosomes (Arribas et al, 1993).
Pardaxin binds to and permeates phospholipid vesicles and its
biological activities appear to stem from these properties (Shai,
1994). We show in this paper that the peptide corresponding
to the N-terminal 1-18 segment, GFFALIPKIISSPLFKTL-
amide, does not show cytolytic activity like pardaxin but has
antibacterial activity against Escherichia coli. When the proline
at position 7 is substituted by alanine, the resultant peptide
shows both cytolytic and antibacterial activity. Replacement
of K by Q in this peptide results in the peptide possessing
only hemolytic activity. The primary structures of pardaxin
and peptides described in this study are shown in Table I.
Materials and methods
Materials
Fmoc amino acids, NovaSyn KR resin and dimethylaminopyri-
dine (DMAP) were obtained from Nova Biochem (UK).
Trifluoroacetic acid (TFA) was purchased from Aldrich (USA).
Synthesis-grade piperidine was procured from Merck (India).
Diisopropylethylamine (DIPEA) and 2-(l//-benzotriazol-l-yl)-
1,1,3,3-tetramethyluronium hexafluorophosphate (HBTU)
were purchased from Applied Biosystems (USA). Synthesis-
grade N-methylpyrrolidone (NMP) was purchased from LOBA
Biochem (India). Lipids were obtained from Avanti Polar
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Table I. Primary structure of pardaxin and related peptides
Peptide Sequence1
Pardaxin (PX) GFFALIPKnSSPLFKTLLSAVGSALSSGEQE
18P GFFALIPKIlSSPLFKTL-amide
18A GFFALIAKTISSPLFKTL-amide
18Q GFFALIAQIISSPLFQTL-amide
"Amino acid residues that are underlined reflect changes from the pardaxin
sequence.
Lipids (Alabaster, AL, USA). Carboxyfluorescein (sodium salt)
was procured from Molecular Probes (USA). All other reagents
were of analytical grade. Unless stated otherwise, all the
experiments were carried out in 150 mM saline buffered to
pH 7.4 by 10 mM HEPES.
Peptide synthesis
The peptides were synthesized on polyamide resins using
Fmoc chemistry (Atherton and Sheppard, 1989) on a Biolynx
4175 Pharmacia LKB Peptide Synthesizer. Fmoc-Leu was
converted into the corresponding symmetrical anhydride and
coupled to NovaSyn KR resin in NMP using DMAP as
catalyst. All the other amino acids were coupled as HBTU
active esters in the presence of an equivalent amount of HOBT
using DIPEA as the catalyst. At the end of the synthesis, the
resin was washed thoroughly with DMF and diethyl ether and
dried in vacuo. The peptides were cleaved from the resin using
a mixture containing TFA, thioanisole, ethanedithiol and phenol
(8.75:0.5:0.5:0.25, v/v) at room temperature for 12 h. All
the peptides contained one major peak when checked on a
Pharmacia Fast Performance Liquid Chromatography (FPLC)
system using a PepRPC reversed-phase column, which was
>85% pure by weight. The peptides were purified using a
linear gradient system consisting of 0.1% (v/v) TFA in water
and 0.1% (v/v) TFA in acetonitrile. The compositions of the
peptides were confirmed by amino acid analysis on an LKB
Alpha Plus 4151 Amino Acid Analyzer after hydrolysis in
vacuo by 6 M HC1.
Antibacterial activity
Different bacterial strains from mid-logarithmic phase cultures
were inoculated into LB medium (Miller, 1972) to a concentra-
tion of -105 CFU/ml. After 6-7 h of incubation at 37°C, the
absorbance of the cultures at 600 nm (A^) were determined.
The Agfjo value observed for the control culture for which no
peptide was added was taken as 100 for the purpose of
calculation of percentage inhibition. Aliquots which showed
maximum inhibition of growth were appropriately diluted
(-15 000 cells/ml), and 20 |il of each of these diluted culture
media were plated onto nutrient agar. plates and incubated at
37°C for 15 h. Peptide concentrations of aliquots which showed
no colony-forming units were taken as the minimal inhibitory
concentrations (MIC). The experiments were performed in
duplicate and triplicate independently.
Outer membrane (OM) and inner membrane (IM)
permeabilization
Escherichia coli transformed with plasmid pBR322 was used
for the permeabilization experiments. The strain was constitu-
tive for |}-galactosidase, a cytoplasmic enzyme and |}-lactam-
ase, a periplasmic enzyme. For the experiments, bacteria were
prepared by inoculating 10 ml of LB medium containing 0.5
mg of ampicillin with organisms picked from a single colony.
After overnight (16 h) incubation at 37°C, the culture was
washed three times with 10 mM sodium phosphate buffer
(PBS), pH 7.4 and resuspended in PBS to a concentration of
~108 CFU/ml (OD = 0.35). A stock solution of 7-(thienyl-2-
acetamido)-3-[2-(4-A'rAf-dimethylaminophenylazo)pyridinium-
methyl]-3-cephem-4-carboxylic acid (PADAC) (from
Calbiochem, USA) was prepared by dissolving the compound
in phosphate buffer to a concentration of 0.5 mg/ml. An o-
nitrophenyl-p-r>galactoside (ONPG) stock solution was pre-
pared at a concentration of 3 mg/ml in PBS. Assay mixtures
contained ~ 106 CFU of E.coli cells per ml of phosphate buffer
containing PADAC or ONPG and peptides. The chromogenic
substrate PADAC is impermeable to the OM and is accessible
to (3-lactamase only when the OM is permeabilized. This is
reflected by a decrease in OD at 570 nm (Lehrer et ai, 1988,
1989). The increase in the OD at 420 nm (in the presence of
peptides) over and above the control, in the absence of peptide
was taken as a measure of IM permeabilization (Lehrer et al.,
1988, 1989).
Lysis of erythrocytes
Human erythrocytes were used for the experiment. The buffy
coat was removed by centrifugation of freshly collected blood
and washing three times with isotonic saline. Erythrocytes
(-2X107 cells) were incubated at 37°C in 10 mM HEPES
buffered saline with different concentrations of test peptides
for 30 min, centrifuged and the absorbance at 540 nm of
the supernatant was measured. The absorbance obtained by
treatment of erythrocytes with 0.1% Triton X-100 was taken
as 100%.
Circular dichroism (CD)
CD measurements were carried out on a Jobin Yvon dichro-
graph V spectropolarimeter which was calibrated using 10-
(+)-camphorsulfonic acid (Chen and Yang, 1977). Spectra
were obtained on samples containing 5 and 10 fiM peptide at
various waterTFE proportions. No concentration dependence
was observed in the spectra in the indicated range. The spectra
were normalized for concentration and path length to obtain
the mean residue ellipticity after baseline correction. All the
measurements were done at 25°C.
Vesicle preparation and model-membrane permeabilization
experiments
Small unilamellar vesicles (SUV) made of pure lipid, dioleoyl-
phosphatidylcholine (DOPC), were essentially prepared by
sonication. The lipid solution in chloroform was taken to
dryness and then dispersed in buffer or buffer containing
carboxyfluorescein (CF) (50 mM CF, 100 mM NaCl, 10 mM
HEPES, pH 7.4) by vortex mixing. The resulting liposome
suspension was sonicated using a sonfier (Branson Sonic
Power, Danbury, CT) until clear solutions were obtained. The
sonicated solution was passed through a Sephadex G-75
column (40X1.5 cm i.d.) to separate CF-entrapped lipid
vesicles from free CF. The elution buffer contained 150 mM
NaCl. The concentration of lipid was estimated by the method
of Stewart (1980). The peptides were added from a stock
solution using a Hamilton syringe to lipid vesicles and the
release of CF as a function of time was recorded continuously.
Results and discussion
Choice of peptides
The peptides chosen for the study are listed in Table I.
Preliminary investigations had indicated that the C-terminal
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Fig. 1. FPLC of purified peptides derived from pardaxin. The peptides were
analysed on a Pharmacia C )8 PepRPC HR 5/5 column Solvent 1: 0.1% TFA
in water Solvent 2: 0.1% TFA in acetonitrile. Elution conditions: linear
gradient from 0% acetonitrile in water containing 0.1 % TFA at 5 nun to
100% acetonitrile containing 0.1% TFA at 45 min. Detection at 214 nm.
segment of pardaxin, KTLLSAVGSALSSSGEQE, did not have
membrane permeabilizing activity. Since positive charges are
presumed to play an important role in determining the mem-
brane activity of peptides related to the N-terminal segment
of pardaxin (Saberwal and Nagaraj, 1993), the N-terminal 18-
residue segment which has two K residues was synthesized
and checked for activity. In pardaxin, PI3 causes structural
distortion in the helix backbone as suggested by CD and NMR
studies (Shai etal., 1990; Zagorski etai, 1991). This distortion
is not present when P13 was replaced by A (Shai et al., 1990).
Since P7 in 18P can also bring about structural distortion and
thereby modulate its activities, an analog wherein P7 was
replaced by A was synthesized. It has been observed that Gin
has an important role in the channel formation of peptides
devoid of charged residues (Fox and Richards, 1982; Mathew
and Balaram, 1983; Karle et al, 1991). Hence, an analog of
18A was synthesized wherein the two lysine residues were
replaced by Q. The grand average hydropathy (GRAVY) values
calculated by the program SOAP developed by Kyte and
Doolittle (1982) for 18P, 18A and 18Q are 11.88, 13.77 and
14.22, respectively. These values indicate that the order of
hydrophobicity amongst the peptides is 18P < 18A < 18Q.
Since retention time on a reversed phase matrix is determined
to a large extent by hydrophobic interaction, the retention
times of the peptides were checked on a C|8 reversed-phase
FPLC column. The profiles of the purified peptides shown in
Figure 1 indicate that the order of hydrophobicity is the
same as indicated by the calculation based on Kyte and
Doolittle's method.
Hemolytic activity
The hemolytic activity of peptides against human erythrocytes
was examined. Peptide 18P did not exhibit hemolytic activity
even at a concentration of 150 (ig/ml, whereas 18A and 18Q
were hemolytic. The activities of 18A, 18Q and 18P are shown
in Figure 2; 100% hemolysis is observed for 18A at a
concentration of 30 fig/ml. 18Q also shows considerable
hemolysis but is relatively less active, as 100% lysis is observed
at 55 (ig/ml. In these concentration ranges, 18P is totally
inactive. Thus, a single switch of P to A has profound effect
on activity. Since 18Q can cause hemolysis, the requirement
of positively charged residues for hemolytic activity is clearly
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Fig. 2. Hemolysis of human erythrocytes as a function of peptide
concentration: (O), 18A; (o), 18Q; (A), 18P. Data points correspond to
means of two independent observations. The variation was <10%
Table II. Antibacterial activity of peptides related to pardaxin
Peptide0 Range of concentration in MIC against 100% hemolysis
which growth inhibition E.coli (ug/ml) (Ug/ml)
was observed (Ug/ml)
PX 3.4-34
18P 4.0-40
18A 10-50
18Q NA
24
34
40
NA
14
NA
33
56
"MIC represents mean values of three independent experiments performed
in duplicate. Peptide 18Q did not inhibit microbial growth at a concentration
of -50 Ug/ml. NA = not active.
not essential.Peptide 18A was, however, less active than PX,
which showed 100% hemolysis at 13 (ig/ml.
Antibacterial activity
The antibacterial activity of the peptides listed in Table I was
examined against E.coli, a Gram-negative bacterium, and the
activities of the peptides are presented in Table II. It was
found that 18P and 18A exhibit activity with comparable MIC,
which is higher than that of PX. 18P, which is not hemolytic,
can inhibit the growth of E.coli; however, 18Q, which is
hemolytic, has no antibacterial activity. The peptides exhibited
activity specifically only against E.coli. Although PX has
potent antibacterial and hemolytic activities, its N-terminal 18-
residue segment has only antibacterial activity. The lack of
activity observed for 18Q suggests the importance of charged
residues as determinants of antibacterial activity, unlike in the
case of hemolysis. The peptides did not show antibacterial
activity against Staphylococcus aureus, a Gram-positive micro-
organism.
Mechanism of antibacterial activity
Since the peptides in Table I are too large to pass through
porin channels in the OM of E.coli, their mode of entry is
likely to be by perturbation of the OM as in the case of
defensins (Lehrer et al., 1989). Hence, the OM permeability
in E.coli transformed with pBR322 was examined in the
presence of 18A, 18P and 18Q. The bacterial cells had
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Fig. 3. Permeabilization of E.coli outer membrane assessed by influx of
PADAC, a chromogenic substrate for the penplasmic enzyme (J-lactamase.
Profiles of membrane permeabilization shown by peptides: (A) 18P and (B)
18A. The numbers next to the lines correspond to peptide concentration
(Hg/ml) and c indicates control where no pepude is present. Details of the
experimental protocol are given in Materials and methods.
P-lactamase in the penplasmic space, which was cryptic for
PADAC unless the OM was permeabilized. This resulted in
hydrolysis of PADAC, an event that can be followed by UV
spectroscopy. Figure 3 shows the hydrolysis of PADAC in the
presence of 18P and 18A. Both peptides cause fairly rapid
hydrolysis of PADAC, indicating the ability of the peptides to
permeabilize the OM. It was found that 18A is more effective
than 18P in this process; 18Q did not have the ability to cause
the influx of PADAC, indicating a requirement for positive
charges for the process. However, the activities of 18A and
18P indicate that even two lysine residues are sufficient for
this purpose. Figure 4 shows the effect of the peptides 18A
and 18P on ONPG (a substrate for P-galactosidase) influx
across the bacterial plasma membrane. Both the peptides
permeabilize the IM at comparable efficiencies.
Studies on N-terminal peptides related to PX reveal that
the N-terminal 18-residue peptide has selective antibacterial
activity. A single amino acid replacement of P to A results in
a peptide possessing both antibacterial and hemolytic activities.
The importance of cationic residues for antibacterial activity
but not for hemolytic activity is borne out by the properties
of 18Q. In order to rationalize the activities of the peptides in
0 0
10 2 0 3 0 4 0 5 0 6 0
Concentration (pg/ml)
Fig. 4. Permeabilization of E.coli inner membrane by peptides assessed by
influx of ONPG, a substrate for cytoplasplasmic P-galactosidase.
terms of structure and membrane permeabilizing abilities,
the conformations of the peptides and activities on model
membranes were examined.
Conformation of peptides
The conformations of 18P, 18A and 18Q were examined in
aqueous medium at pH 7.4 and varying proportions of TFE.
The results are presented in Figure 5. In an aqueous environ-
ment, 18P and 18A do not have a significant population in
ordered conformation. With increasing TFE, spectra with
double minima characteristic of a helical conformation are
observed. The contribution of various secondary structures
was estimated by the method of convex constraint analysis
(Perczel et al, 1991, 1992). Only an - 2 1 % helical content is
observed for 18P even in neat TFE. For 18A, the analysis
indicates -40% helical content in neat TFE with a random
contribution of -60%. The lower helical content observed for
18P probably arises owing to the presence of P, especially P7,
as a replacement of P7 by A results in an increased helical
content. Alternatively, it is possible that the helical structure
in 18P is distorted, as distortions from regular helix or
P structures are known to result in spectra different from those
for idealized helix or P structures (Manning et al., 1988).
Peptide 18Q adopts a P structure in an aqueous environment.
With increasing amounts of TFE, the single minimum persists
until -65% TFE. At 100% TFE, a spectrum with double
minima is observed. Convex constraint analysis of the spectra
with a single minimum indicates p and random structures with
no helical content. Even in neat TFE, p structure (31%)
predominates over helical structure (19%). Random structure
contributes 50%. Now, although TFE promotes helical con-
formation, it does so only if the peptide has an intrinsic
propensity to form a helix (Dyson et al., 1988, 1992). CD
results indicate that only 18A has a propensity for helix
conformation. In 18P, the presence of Pro prevents the forma-
tion of a long helical stretch and in neat TFE, the fraction of
molecules in ordered conformation probably exists as a dis-
torted helix. The CD spectra of 18Q in micelles and lipid
vesicles are shown in Figure 6. The spectra indicate that the
peptide adopts a P-structure in lipid vesicles.
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Model membrane permeabilization
The ability of 18P, 18A and 18Q to perturb model membranes
was assessed by monitoring the release of entrapped solutes
such as CF. This method has been used extensively to obtain
details about the channel-forming properties of peptides in
Fig. 7. Ability of peptides to cause the release of entrapped CF from
DOPC vesicles: (A) I8P; (B) 18A; (C) 18Q. Numbers adjacent to the lines
correspond to the concentration (Hg/ml) of peptides added. Lipid = 100
lipid vesicles (Menestrina, 1988; Schwarz and Robert, 1990;
Shai et al, 1990; Vaz et al, 1993). The CF release profiles
from DOPC vesicles in the presence of peptides are shown in
Figure 7. The profiles indicate that 18A is the most effective
in permeabilizing the vesicles, followed by 18P and 18Q. The
membrane activity of 18Q and the CD data together indicate
that a helical conformation is not an absolute prerequisite for
membrane association. Although our CD data do not permit
us to arrive at a molecular structure for 18Q, it is likely that
it forms an amphipathic p-sheet, with peptide molecules
connected by intermolecular hydrogen bonding. The greater
membrane-permeabilizing activity of 18A over 18P correlates
with their relative hydrophobicities. However, 18Q, although
more hydrophobic than 18A or 18P, is less effective in
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permeabilizing model membranes. This observation suggests
that correlation of membrane activity and hydrophobicity may
be valid only in cases where peptide structures are similar as
with some model peptides (Blondelle and Houghten, 1992).
In our search for peptides possessing specific biological
activity, we have found that 18P, the N-terminal segment of
PX, has only antibacterial activity with no hemolytic activity
even at high concentrations. The properties of other analogs
generated from this peptide as well as conformational and
membrane permeabilization studies suggest requirements for
specific activity. The analog 18A, which has both antibacterial
and hemolytic activities, is hydrophobic and cationic, has a
strong propensity to occur in helical conformation and also
permeabilizes model membranes most effectively. The antibac-
terial peptide 18P is cationic and less hydrophobic, has a low
propensity to occur in a helical conformation and is less
effective in permeabilizing lipid membranes than 18A. The
analog 18Q, which has only hemolytic activity, is the most
hydrophobic and devoid of net charge. Thus, an 'inefficient'
membrane permeabilizing peptide has selective biological
activity. In red blood cells and other eukaryotic cells, the
volume-regulating ability of Na+ pumps in the plasma mem-
brane has to be overcome for lysis to occur by a colloid
osmotic mechanism (Pasternak et al., 1985). If the peptide
cannot perturb the membrane to an extent where the volume-
regulating ability is not overcome, no lysis occurs, which is
the case with an 'inefficient' channel former. The bacterial
plasma membrane has all the respiratory enzymes and a
membrane potential is necessary for proper functioning
(Lughtenberg and Van Alphen, 1983). Even a slight perturba-
tion would result in loss of membrane functions. Hence, an
'inefficient' channel former can have antimicrobial activity,
provided, of course, it can gain access to the IM. The activities
of the peptides used in this study indicate that while positive
charges are essential, even two lysines are sufficient for OM
perturbation.
In summary, our studies indicate that selective antibacterial
or hemolytic activities of peptides may be explained by their
biophysical properties. It should be possible rationally to
design and engineer short peptides having selective activity
based on biophysical principles such as conformation, mem-
brane permeabilizing ability, hydrophobicity and net charge.
Acknowledgement
We thank V.MDhople for amino acid analysis.
References
Andreu,D., UbachJ., BomanJ.A., Wahlin.B., Wade,D., Merrifield.R.B. and
Boman,H.G. (1992) FEBS Lett., 296, 190-194.
Arribas.M., BlasiJ., Lazarovici.P. and MarsalJ. (1993) J. Neurochem., 60,
552-558.
Atherton.E. and Sheppard.R.C. (1989) Solid Phase Peptide Synthesis: A
Practical Approach. IRL Press, Oxford.
Bevins.C.L. and Zasloft,M. (1990) Annu. Rev. Biochem. 59, 395-414
Blondelle.S.E. and Houghten,R.A. (1992) Biochemistry, 31, 12688-12694.
Blondelle.S.E., Takahashi.E., Weber.P.A. and Houghten,R.A. (1994)
Antimicwb. Agents Chemolher., 38, 2280-2286.
Boman.H.G. and Hultmark,D. (1987) Annu. Rev. Microbiol., 41, 103-126.
Boman.H.G., Wade,D., Boman.I.A., Wahlin.B. and Mernfield.R.B. (1989)
FEBS Lett., 259, 103-106.
Boman.H.C. (1991) Cell, 65, 205-207.
Chen,G.C. and YangJ.T. (1977) Anal Lett., 10, 1195-1207.
Christensen.B., FinkJ., Merrifield.R.B. and Mauzerall.D. (1988) Proc. Natl
Acad. Sci. USA, 85, 5072-5076.
DeGrado,W.F. and LearJ.D. (1985) J. Am. Chem. Soc., 107, 7684.
Dhople.V.M. and Nagaraj.R. (1995) Protein Engng, 8, 315-318.
Duclohier.H., Molle.G. and Spach.G. (1989) Bwphys. J., 56, 1017-1021.
Dyson.HJ, Rancejvi., Houghten.R.A., Wright.P.E. and Lemer.R.A. (1988)
J. Mol. Bio/., 201, 201-218.
Dyson.HJ., Merutka,G., WalthoJ.P, Lerner.R.A. and Wright.P.E. (1992)
J. Mol. Biol, 226, 795-817.
Fox.R.O. and Richards.F.M. (1982) Nature, 300, 325-330.
Hill.C.P, YeeJ., Selsted.ME. and Eisenberg,D. (1991) Science, 251, 1481-
1485.
Houghten.R.A., Pinilla,C, Blondelle.S.E., AppelJ.R., Dooley.C.T. and
CuervoJ.H. (1991) Nature, 354, 84-86.
Hultmark.D. (1993) Trends Genet., 9, 178-183.
Kagan.B.L., Selsted.M.E., Ganz,T. and Lehrer.R.T. (1990) Proc. Nail Acad.
Sci. USA, 87, 210-214.
Karle.I.L., Flippen-AndersonJ.L., Agarwalla.S. and Balaram,P. (1991) Proc.
Natl Acad. Sci. USA, 88, 5307-5311.
KyteJ. and Doolittle.R.F. (1982) J. Mol. Biol., 157, 105-132.
Lazarovichi,P., Primorjvl. and Loew.L.M. (1986) J. Biol. Chem., 261,
16704-16713.
Lazarovichi,P. and Lelkes.P.I. (1993) J. Pharmacol. Exp. Then, 263, 1317-
1326.
Lee,S., Mihara.H., Aoyagi.H., Kato.T., Izumiya,N. and Yamasaki.N. (1986)
Biochim. Biophys. Ada, 862, 211-219.
Lehrer,R_T, Barton.A. and Ganz,T. (1988) J. Immunol. Methods, 108, 153-158.
Lehrer,R.T., Barton.A., Daher.K.A., Harwig.S.S.L., Ganz,T. and Selsted,M.
(1989) J. Clin. Invest., 84, 553-561.
Lehrer,R.T., Ganz.T. and Selsted.M.E. (1991) Cell, 64, 229-230.
Lughtenberg,B. and Van Alphen.L. (1983) Biochim. Biophys. Ada, 737,
51-115.
Manning,M.C., Illangasekare.M. and Woody.R.W. (1988) Biophys. Chem., 31,
77-86.
Mathew.M.K. and Balaram.P. (1983) FEBS Lett., 157, 1-5.
Menestrina,G. (1988) FEBS Lett., 232, 217-220.
MillerJ.H. (1972) Experiments in Molecular Genetics. Cold Spring Harbor
Laboratory Press, Cold Spring Harbor, NY.
Moran.A., Korchak.Z., Moran.N. and Primor,N. (1984) In Bolis,L.,
ZadunaiskyJ. and Gilles.R. (eds), Toxins, Drugs and Pollutants in Marine
Animals. Springer, Berlin, pp. 13—25.
Pastemak.C.A., Bashford.C.L. and Micklem.KJ. (1985)7. Biosci., 8, (Suppl.),
273-291.
Perczel,A., Hollosi.M., Tusnady.G. and Fasraan.G.D. (1991J Protein Engng,
45, 669-679
Perczel,A., Park.K. and Fasman.G.D. (1992) Anal Biochem., 203, 83-93.
Saberwal.G. and Nagaraj.R. (1989) Biochim. Biophys. Ada, 984, 360-364.
Saberwal.G. and Nagaraj.R. (1993) Biochim. Biophys. Ada, 1151, 43-50.
Sansom.M.S.P. (1991) Prog. Biophys. Mol. Biol., 55, 139-235.
Schwarz.G. and Robert,G.H. (1990) Biophys. J., 58, 577-583.
Shai.Y. (1994) Toxicology, 87, 109-129.
Shai.Y., BachA and Yanovsky.A. (1990) J. Biol Chem., 265, 20202-20209.
Sitaram,N. and Nagaraj.R. (1990) / Biol. Chem., 265, 10438-10442.
Sitaram.N., Chandy,M., Pillai.V.N.R. and Nagaraj.R. (1992) Antimicwb.
Agents Chemother, 36, 2468-2472.
Sitaram,N., Subbalakshmi.C. and Nagaraj.R. (1993) FEBS Lett., 328, 239-242.
Sitaram,N., Subbalakshmi.C. and Nagaraj.R. (1995) Int. J. Peptide Protein
Res., 46, 166-173
StewartJ.C.M. (1980) Anal Biochem., 104, 10-14.
Thennarasu.S. and Nagaraj.R. (1995) Int. J. Peptide Protein Res., 46, 480-486.
Vaz,G.A., Waal.A.D., BerdenJ.A. and Westerhoff.H.V. (1993) Biochemistry,
32, 5365-5372.
Zagorski.M.G., Norman,D.G., Barrow.CJ., Iwashita,T., Tachibana,K. and
PatelJD.J. (1991) Biochemistry, 30, 8009-8017.
Received July 18, 1995; revised June 28, 1996; accepted July 2, 1996
1224
 by guest on Novem
ber 21, 2010
peds.oxfordjournals.org
D
ow
nloaded from
 
